Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 88 filers reported holding Y-MABS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $554,281 | -19.0% | 101,703 | +0.9% | 0.00% | 0.0% |
| Q2 2023 | $684,452 | -9.4% | 100,803 | -33.2% | 0.00% | 0.0% |
| Q1 2023 | $755,508 | +21.4% | 150,800 | +18.2% | 0.00% | 0.0% |
| Q4 2022 | $622,483 | -43.8% | 127,558 | +66.1% | 0.00% | -50.0% |
| Q3 2022 | $1,108,000 | -26.1% | 76,817 | -22.5% | 0.00% | 0.0% |
| Q2 2022 | $1,499,000 | +37.0% | 99,094 | +7.6% | 0.00% | +100.0% |
| Q1 2022 | $1,094,000 | +64.5% | 92,100 | +124.6% | 0.00% | +100.0% |
| Q4 2021 | $665,000 | -43.2% | 41,000 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $1,170,000 | -15.6% | 41,000 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $1,386,000 | +11.8% | 41,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,240,000 | -48.7% | 41,000 | -16.0% | 0.00% | -50.0% |
| Q4 2020 | $2,416,000 | +11.4% | 48,800 | -13.6% | 0.01% | +20.0% |
| Q3 2020 | $2,169,000 | +1.8% | 56,500 | +14.6% | 0.01% | -16.7% |
| Q2 2020 | $2,130,000 | +98.1% | 49,300 | +19.7% | 0.01% | +50.0% |
| Q1 2020 | $1,075,000 | +12.4% | 41,200 | +34.6% | 0.00% | +100.0% |
| Q4 2019 | $956,000 | +19.9% | 30,600 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $797,000 | +245.0% | 30,600 | +203.0% | 0.00% | +100.0% |
| Q2 2019 | $231,000 | – | 10,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 2,194,278 | $108,639,000 | 6.47% |
| Memorial Sloan Kettering Cancer Center | 216,916 | $10,740,000 | 4.55% |
| Burrage Capital Management LLC | 114,962 | $5,692,000 | 4.34% |
| MPM BioImpact LLC | 674,582 | $33,398,000 | 2.88% |
| First Light Asset Management, LLC | 635,652 | $31,471,000 | 2.33% |
| Cormorant Asset Management, LP | 1,661,647 | $82,268,000 | 1.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 219,419 | $10,863,000 | 1.05% |
| ORACLE INVESTMENT MANAGEMENT INC | 126,342 | $6,255,000 | 0.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 131,016 | $6,487,000 | 0.58% |
| Artal Group S.A. | 285,028 | $14,112,000 | 0.30% |